• Presentation

Lapatinib + Capecitabine vs. Capecitabine alone for ErbB2+ Metastatic Breast Cancer: Quality-of-Life Assessment

Citation

Zhou, X., Segreti, A., Cella, D., Cameron, D., Geyer, C., Amonkar, M. M., ... Walker, M. D. (2008, April). Lapatinib + Capecitabine vs. Capecitabine alone for ErbB2+ Metastatic Breast Cancer: Quality-of-Life Assessment. Presented at 6th European Breast Cancer Conference, .

Abstract